(4,5,3',4'-Tetrakis-benzyloxy-6'-hydroxymethyl-6,2'-dimethoxy-biphenyl-2-yl)-methanol | 154675-12-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 单宁
• 英文名称: (4,5,3',4'-Tetrakis-benzyloxy-6'-hydroxymethyl-6,2'-dimethoxy-biphenyl-2-yl)-methanol
• 英文别名: 2,2'-Dimethoxy-3,3',4,4'-tetrabenzyloxy-6,6'-bis(hydroxymethyl)biphenyl；[2-[6-(hydroxymethyl)-2-methoxy-3,4-bis(phenylmethoxy)phenyl]-3-methoxy-4,5-bis(phenylmethoxy)phenyl]methanol
• CAS: 154675-12-4
• 化学式: C₄₄H₄₂O₈
• 分子量: 698.813
• InChiKey: MBCDJJVKPHXHSA-UHFFFAOYSA-N

物化性质

• 沸点：
  807.9±65.0 °C(predicted)
• 密度：
  1.227±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  52
• 可旋转键数：
  17
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  95.8
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  (4,5,3',4'-Tetrakis-benzyloxy-6'-hydroxymethyl-6,2'-dimethoxy-biphenyl-2-yl)-methanol 在 manganese(IV) oxide 作用下， 以 苯 为溶剂， 以75%的产率得到4,5,4',5'-Tetrakis-benzyloxy-6,6'-dimethoxy-biphenyl-2,2'-dicarbaldehyde
  参考文献：
  名称：

  Kashiwada; Huang; Ballas, Journal of Medicinal Chemistry, 1994, vol. 37, # 1, p. 195 - 200

  摘要：

  DOI：
• 作为产物：
  描述：

  鞣花酸 在 lithium aluminium tetrahydride 、 potassium carbonate 、 potassium iodide 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 17.5h， 生成 (4,5,3',4'-Tetrakis-benzyloxy-6'-hydroxymethyl-6,2'-dimethoxy-biphenyl-2-yl)-methanol
  参考文献：
  名称：

  Kashiwada; Huang; Ballas, Journal of Medicinal Chemistry, 1994, vol. 37, # 1, p. 195 - 200

  摘要：

  DOI：

文献信息

• Anti-AIDS (Acquired Immune Deficiency Syndrome) Agents. 17. New Brominated Hexahydroxybiphenyl Derivatives as Potent Anti-HIV Agents
  作者：Lan Xie、Jing-Xi Xie、Yoshiki Kashiwada、L. Mark Cosentino、Shwu-Huey Liu、Rekha B. Pai、Yung-Chi Cheng、Kuo-Hsiung Lee

  DOI：10.1021/jm00016a002

  日期：1995.8

  Sixteen biphenyl derivatives were synthesized and evaluated for their inhibitory activity against HIV-1 replication in acutely infected H9 cells. 3-Bromo- (4) and 3,3'-dibromo-4,4'-dimethoxy-5,6,5',6'-bis(methylenedioxy)-2,2' -bis(methoxycarbonyl)biphenyl (5) demonstrated potent anti-HIV activity with EC(50) values of 0.52 and 0.23 mu g/mL and therapeutic index values of > 190 and > 480, respectively. A comparison, of the anti-HIV activity of these biphenyl derivatives suggested that the types of substituents on the phenolic hydroxy groups rather than the number of bromine(s) on the aromatic rings are important to the enhanced anti-HIV activity. Compounds 4 and 5 also showed potent inhibitory activity against HIV-1 reverse transcriptase in a template-primer dependent manner. The site of inhibition of HIV could be related to inhibition of this enzyme. Compounds 4 and 5 did not induce virus expression from the chronic HIV-1-infected cell lines ACH-2 and U1. Furthermore, these two agents did not inhibit an increase in virus production from the chronic HIV-1-infected cell lines when the phorbol ester PMA was present.
• Kashiwada Yoshiki, Huang Li, Kikuskie Robert E., Bodner Anne J., Lee Kuo-+, Bioorg. and med. chem. lett., 2 (1992) N 3, S 235-238
  作者：Kashiwada Yoshiki, Huang Li, Kikuskie Robert E., Bodner Anne J., Lee Kuo-+

  DOI：——

  日期：——
• BROMINATED HEXAHYDROXYBIPHENYL DERIVATIVES
  申请人：UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

  公开号：EP0837677B1

  公开（公告）日：2006-03-29
• US5612341A
  申请人：——

  公开号：US5612341A

  公开（公告）日：1997-03-18
• Kashiwada; Huang; Ballas, Journal of Medicinal Chemistry, 1994, vol. 37, # 1, p. 195 - 200
  作者：Kashiwada、Huang、Ballas、Jiang、Janzen、Lee

  DOI：——

  日期：——